glp 1 and cardiovascular benefits The conversation around GLP-1 medications is growing, it goes beyond the number on the scale. According to the American Heart Association, evidence suggests GLP-1s may support heart health and help reduce GLP-1 Receptor Agonists in Heart

This approach allows for tolerance assessment and reduces the likelihood of adverse effects

GLP-1 drugs also called GLP-1 agonists were originally developed to treat type 2 diabetes

A randomized Phase 2a trial published in Nature Medicine demonstrated significant reductions in liver fat content in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)

Rather than navigating fragmented care, everything is handled in one placefrom your initial consultation to prescription review and delivery

Retatrutide is a novel, investigational injectable medication designed for weight reduction and metabolic optimization

After starting GLP-1s, these patients experienced higher rates of dizziness, fainting and other events related to low blood pressure, also known as hypotension